342 related articles for article (PubMed ID: 24055548)
1. Invasive aspergillosis in patients with severe alcoholic hepatitis.
Gustot T; Maillart E; Bocci M; Surin R; Trépo E; Degré D; Lucidi V; Taccone FS; Delforge ML; Vincent JL; Donckier V; Jacobs F; Moreno C
J Hepatol; 2014 Feb; 60(2):267-74. PubMed ID: 24055548
[TBL] [Abstract][Full Text] [Related]
2. Invasive mycosis in medical intensive care unit patients with severe alcoholic hepatitis.
Lahmer T; Messer M; Schwerdtfeger C; Rasch S; Lee M; Saugel B; Schmid RM; Huber W
Mycopathologia; 2014 Apr; 177(3-4):193-7. PubMed ID: 24710759
[TBL] [Abstract][Full Text] [Related]
3. Infliximab monotherapy for severe alcoholic hepatitis and predictors of survival: an open label trial.
Sharma P; Kumar A; Sharma BC; Sarin SK
J Hepatol; 2009 Mar; 50(3):584-91. PubMed ID: 19155081
[TBL] [Abstract][Full Text] [Related]
4. The amount of alcohol consumption negatively impacts short-term mortality in Mexican patients with alcoholic hepatitis.
Altamirano J; Higuera-de laTijera F; Duarte-Rojo A; Martínez-Vázquez MA; Abraldes JG; Herrera-Jiménez LE; Michelena J; Zapata L; Perez-Hernández J; Torre A; Gonzáles-González JA; Cardenas A; Dominguez M; Arroyo V; Ginès P; Caballería J; Bataller R
Am J Gastroenterol; 2011 Aug; 106(8):1472-80. PubMed ID: 21556041
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of serum galactomannan in mixed ICU patients: a retrospective observational study.
Teering S; Verreth A; Peeters A; Van Regenmortel N; De Laet I; Schoonheydt K; Dits H; Van De Vyvere M; Libeer C; Meersseman W; Malbrain ML
Anaesthesiol Intensive Ther; 2014; 46(3):145-54. PubMed ID: 25078766
[TBL] [Abstract][Full Text] [Related]
6. Galactomannan in bronchoalveolar lavage fluid: a tool for diagnosing aspergillosis in intensive care unit patients.
Meersseman W; Lagrou K; Maertens J; Wilmer A; Hermans G; Vanderschueren S; Spriet I; Verbeken E; Van Wijngaerden E
Am J Respir Crit Care Med; 2008 Jan; 177(1):27-34. PubMed ID: 17885264
[TBL] [Abstract][Full Text] [Related]
7. Model of disease severity in alcoholic hepatitis and novel prognostic insights.
Enciu VT; Ologeanu PM; Călin-Necula AM; Moldoveanu AC; Oprea-Călin G; Fierbinţeanu-Braticevici C
Rom J Intern Med; 2024 Jun; 62(2):194-202. PubMed ID: 38180800
[TBL] [Abstract][Full Text] [Related]
8. Predicting short-term and long-term mortality of hospitalized Portuguese patients with alcoholic hepatitis.
Fernandes SR; Marques da Costa P; Vítor S; Carvalho JR; Santos P; Moura CM; Cortez-Pinto H; Ramalho F; Velosa J
Eur J Gastroenterol Hepatol; 2017 Oct; 29(10):1141-1148. PubMed ID: 28628497
[TBL] [Abstract][Full Text] [Related]
9. Application of prognostic scores in the STOPAH trial: Discriminant function is no longer the optimal scoring system in alcoholic hepatitis.
Forrest EH; Atkinson SR; Richardson P; Masson S; Ryder S; Thursz MR; Allison M;
J Hepatol; 2018 Mar; 68(3):511-518. PubMed ID: 29175535
[TBL] [Abstract][Full Text] [Related]
10. Study on invasive aspergillosis using galactomannan enzyme immunoassay and determining antifungal drug susceptibility among hospitalized patients with hematologic malignancies or candidates for organ transplantation.
Ardi P; Daie-Ghazvini R; Hashemi SJ; Salehi MR; Bakhshi H; Rafat Z; Zareei M; Getso M; Basiri S; Sarwestani HK; Boroujeini ZB; Ahmadikia K
Microb Pathog; 2020 Oct; 147():104382. PubMed ID: 32663605
[TBL] [Abstract][Full Text] [Related]
11. Nine scoring models for short-term mortality in alcoholic hepatitis: cross-validation in a biopsy-proven cohort.
Papastergiou V; Tsochatzis EA; Pieri G; Thalassinos E; Dhar A; Bruno S; Karatapanis S; Luong TV; O'Beirne J; Patch D; Thorburn D; Burroughs AK
Aliment Pharmacol Ther; 2014 Apr; 39(7):721-32. PubMed ID: 24612165
[TBL] [Abstract][Full Text] [Related]
12. Combination of Gene Expression Signature and Model for End-Stage Liver Disease Score Predicts Survival of Patients With Severe Alcoholic Hepatitis.
Trépo E; Goossens N; Fujiwara N; Song WM; Colaprico A; Marot A; Spahr L; Demetter P; Sempoux C; Im GY; Saldarriaga J; Gustot T; Devière J; Thung SN; Minsart C; Sersté T; Bontempi G; Abdelrahman K; Henrion J; Degré D; Lucidi V; Rubbia-Brandt L; Nair VD; Moreno C; Deltenre P; Hoshida Y; Franchimont D
Gastroenterology; 2018 Mar; 154(4):965-975. PubMed ID: 29158192
[TBL] [Abstract][Full Text] [Related]
13. A prognostic evaluation and management of alcoholic hepatitis.
Rana R; Wang SL; Li J; Xia L; Song MY; Yang CQ
Minerva Med; 2017 Dec; 108(6):554-567. PubMed ID: 28602070
[TBL] [Abstract][Full Text] [Related]
14. Efficacy of granulocyte colony stimulating factor in patients with severe alcoholic hepatitis with partial or null response to steroid (GRACIAH trial): study protocol for a randomized controlled trial.
Cho Y; Park YS; Kim HY; Kim W; Lee HJ; Kim DJ
Trials; 2018 Dec; 19(1):696. PubMed ID: 30577864
[TBL] [Abstract][Full Text] [Related]
15. Correlation between high-resolution computed tomography and galactomannan antigenemia in adult hematologic patients at risk for invasive aspergillosis.
Hidalgo A; Parody R; Martino R; Sánchez F; Franquet T; Giménez A; Blancas C
Eur J Radiol; 2009 Jul; 71(1):55-60. PubMed ID: 18468830
[TBL] [Abstract][Full Text] [Related]
16. The Lille model: a new tool for therapeutic strategy in patients with severe alcoholic hepatitis treated with steroids.
Louvet A; Naveau S; Abdelnour M; Ramond MJ; Diaz E; Fartoux L; Dharancy S; Texier F; Hollebecque A; Serfaty L; Boleslawski E; Deltenre P; Canva V; Pruvot FR; Mathurin P
Hepatology; 2007 Jun; 45(6):1348-54. PubMed ID: 17518367
[TBL] [Abstract][Full Text] [Related]
17. Use of Aspergillus fumigatus real-time PCR in bronchoalveolar lavage samples (BAL) for diagnosis of invasive aspergillosis, including azole-resistant cases, in high risk haematology patients: the need for a combined use with galactomannan.
Mikulska M; Furfaro E; De Carolis E; Drago E; Pulzato I; Borghesi ML; Zappulo E; Raiola AM; Grazia CD; Del Bono V; Cittadini G; Angelucci E; Sanguinetti M; Viscoli C
Med Mycol; 2019 Nov; 57(8):987-996. PubMed ID: 30753590
[TBL] [Abstract][Full Text] [Related]
18. Infection in patients with severe alcoholic hepatitis treated with steroids: early response to therapy is the key factor.
Louvet A; Wartel F; Castel H; Dharancy S; Hollebecque A; Canva-Delcambre V; Deltenre P; Mathurin P
Gastroenterology; 2009 Aug; 137(2):541-8. PubMed ID: 19445945
[TBL] [Abstract][Full Text] [Related]
19. A prospective comparison of galactomannan in bronchoalveolar lavage fluid for the diagnosis of pulmonary invasive aspergillosis in medical patients under intensive care: comparison with the diagnostic performance of galactomannan and of (1→ 3)-β-d-glucan chromogenic assay in serum samples.
Acosta J; Catalan M; del Palacio-Peréz-Medel A; Lora D; Montejo JC; Cuetara MS; Moragues MD; Ponton J; del Palacio A
Clin Microbiol Infect; 2011 Jul; 17(7):1053-60. PubMed ID: 20825441
[TBL] [Abstract][Full Text] [Related]
20. Diagnosis of invasive aspergillosis in lung transplant recipients by detection of galactomannan in the bronchoalveolar lavage fluid.
Pasqualotto AC; Xavier MO; Sánchez LB; de Oliveira Costa CD; Schio SM; Camargo SM; Camargo JJ; Sukiennik TC; Severo LC
Transplantation; 2010 Aug; 90(3):306-11. PubMed ID: 20548265
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
